Trifluoroacetic acid → HCID 58529315, compound

Participants

Reaction Steps

To a suspension of (2-(4-[4-Amino-5-(3-amino-2-benzyl-2H-indazol-6-yl)-pyrrolo[2,1-f][1,2,4]triazin-7-yl]-piperidin-1-yl)-2-oxo-ethyl)-methyl-carbamic acid tart-butyl ester (30 mg, 0.049 mmol) in anhydrous DCM (1.0 mL) was added trifluoroacetic acid (1.0 mL), and the reaction mixture was stirred at rt. After 1 h, the mixture was poured into EtOAc (75 mL), and the organic phase was washed with aqueous, saturated NaHCO3 solution (3×25 mL), water and brine, dried over Na2SO4, filtered, and concentrated in vacuo. Trituration with DCM-hexane afforded the title compound (24.7 mg, 98.5%) as a pink solid. 1H NMR (300 MHz, DMSO-d6) δ 7.88 (s, 1H), 7.71 (d, 1H), 7.34 to 7.29 (m, 2H), 7.27 to 7.21 (m, 3H), 7.15 (s, 1H), 6.73 (dd, 1H), 6.54 (s, 1H), 6.37 (broad s, 2H), 5.38 (s, 2H), 4.50 (d, 1H), 3.90 (d, 1H), 3.42 to 3.27 (m, 3H), 3.13 (t, 1H), 2.76 to 2.66 (m, 1H), 2.26 (s, 3H), 2.05 to 1.99 (m, 3H), 1.68 to 1.49 (m, 2H); ES-MS m/z 510.1 [M+H]+, RT (min) 1.56.

Provenance & Evidence